HighLight Capital Terms and Conditions
  • Home
  • About
  • Team
  • Portfolio
  • News
  • Contact Us
HighLight Capital Terms and Conditions

Latest News

ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
2023-05-20

ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS

Etana has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Venture.
China's HighLight hits first close onlife sciences fund, targets $650m
2022-09-16

China's HighLight hits first close onlife sciences fund, targets $650m

HighLight Capital, a China-based life sciences investor, has completeda first close of USD 540m on its fourth US dollar-denominated fund.
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
2021-07-21

Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

Imago a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms, announced IPO
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
2021-05-07

Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO

Singular, which is developing novel next generation sequencing and multiomics technologies, filed with the SEC to raise up to $100M in an IPO
Pharmaron Announced 117 Million H-Shares on the Hong Kong Stock Exchange
2019-11-28

Pharmaron Announced 117 Million H-Shares on the Hong Kong Stock Exchange

Pharmaron announced today that 117 million H-shares are listed on the Main Board of The Stock Exchange of Hong Kong
Pharmaron Announces Listing of Initial Public Offering on Shenzhen Stock Exchange
2019-01-28

Pharmaron Announces Listing of Initial Public Offering on Shenzhen Stock Exchange

Pharmaron announced today its initial public offering (IPO) on the Shenzhen Stock Exchange(Stock Code: 300759.SZ)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 31 records in total
HighLight Capital Terms and Conditions
Home
About
Team
Portfolio
News
Contact Us
Copyright © 2014-2025 HighLight Capital Terms and Conditions. All Rights Reserved.